Implant-supported rehabilitation of unicystic ameloblastoma: A 2 years follow-upclinical report

Nitasha Gandhi, Sumir Gandhi, Nirmal Kurian

CHRISMED Journal of Health and Research 2017 4(2):132-135

Ameloblastoma is a rare, benign, epithelial odontogenic tumor that tends to grow slowly in the mandible or maxilla but is locally invasive and can be highly destructive of the surrounding dental anatomy. Osseous resection with clear margins is the recommended treatment modality taking into consideration of 50% rate of recurrence within 5 postoperative years. Loss of the continuity of the mandible destroys the balance and the symmetry of mandibular function, leading to altered mandibular movements and deviation of the residual fragment toward the surgical side. The use of osseointegrated dental implants for rehabilitation is advisable, as it allows the recovery of the masticatory function. This clinical report reveals 2 years follow-up of rehabilitation of a 19-year-old patient who underwent surgical enucleation for the treatment of unicystic ameloblastoma followed by dental implant placement.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2mLprYX
via IFTTT